 |
|
Dartmouth researchers find that arsenic triggers unique mechanism in rare leukemia
January 09, 2007Dartmouth Medical School (DMS) researchers have identified a new way that arsenite, a form of arsenic, acts in treating a rare cancer known as APL, or acute promyelocytic leukemia. Their study is published in the Jan. 3 issue of the Journal of the National Cancer Institute.
"We knew that arsenite was particularly effective against this cancer, and we wanted to figure out why," says Sutisak Kitareewan, an author on this paper and an instructor of pharmacology and toxicology at DMS. "Now we know that arsenite destabilizes lysosomes, a part of a cell that contains certain enzymes, which, when released, often kill APL cells."
APL is caused by the swapping of chromosomes 15 and 17, which forms a fusion protein. This fusion protein prevents certain blood cells from maturing and leads to an accumulation of immature leukemia cells. Researchers found that arsenite causes rapid destabilization of the lysosome in cells, and that breaks the lysosome apart, releasing enzymes that destroy these particular kinds of leukemia cells.
"We hope this finding will be used to inform further research into treating APL," says co-author Ethan Dmitrovsky, professor of medicine and of pharmacology and toxicology, who is also affiliated with the Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center. "We also hope that further studies examine if this same mode of action is the basis for arsenic toxicity."
In addition to Kitareewan and Dmitrovsky, the other authors on the paper include B.D. Roebuck, professor of pharmacology and toxicology; Eugene Demidenko, research professor of community and family medicine in the area of biostatistics; and Roger Sloboda, the Ira Allen Eastman Professor of Biological Sciences. Dmitrovsky also holds the Andrew G. Wallace Professorship at Dartmouth.
This research was supported by funds from the National Institutes of Health and the National Science Foundation.
Dartmouth Medical School
"We hope this finding will be used to inform further research into treating APL," says co-author Ethan Dmitrovsky, professor of medicine and of pharmacology and toxicology, who is also affiliated with the Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center. "We also hope that further studies examine if this same mode of action is the basis for arsenic toxicity."
In addition to Kitareewan and Dmitrovsky, the other authors on the paper include B.D. Roebuck, professor of pharmacology and toxicology; Eugene Demidenko, research professor of community and family medicine in the area of biostatistics; and Roger Sloboda, the Ira Allen Eastman Professor of Biological Sciences. Dmitrovsky also holds the Andrew G. Wallace Professorship at Dartmouth.
This research was supported by funds from the National Institutes of Health and the National Science Foundation.
Dartmouth Medical School
Leukemia Current Events and Leukemia News RSSOHSU Knight Cancer Institute researcher: study may result in more targeted drugs for GIST
According to Oregon Health & Science University Knight Cancer Institute researchers, there is strong evidence that patients can have varying clinical responses to medications depending on the specific makeup of their cancer.
The miseries of allergies just may help prevent some cancers, study finds
There may be a silver -- and healthy -- lining to the miserable cloud of allergy symptoms: Sneezing, coughing, tearing and itching just may help prevent cancer -- particularly colon, skin, bladder, mouth, throat, uterus and cervix, lung and gastrointestinal tract cancer, according to a new Cornell study.
Mayo Clinic Researchers Find Predictive Tests and Early Treatment Delay Progression of Blood Cell Cancer
Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer.
UC Davis researchers discover Achilles' heel in pancreatic cancer
UC Davis Cancer Center researchers have discovered a metabolic deficiency in pancreatic cancer cells that can be used to slow the progress of the deadliest of all cancers.
Washington University scientists first to sequence genome of cancer patient
For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots.
Gene variations alter risk of esophageal cancer
Variations in a common gene pathway may affect esophageal cancer risk, a dangerous and rapidly increasing type of cancer, according to research by scientists at The University of Texas M. D. Anderson Cancer Center.
New therapeutic target identified for rheumatoid arthritis
Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis.
Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Syracuse University researchers discover new way to attack some forms of leukemia
Each year, some 29,000 adults and 2,000 children are diagnosed with leukemia, a form of cancer that is caused by the abnormal production of white blood cells in the bone marrow.
Silencing a protein could kill T-Cells, reverse leukemia
Blocking the signals from a protein that activates cells in the immune system could help kill cells that cause a rare form of blood cancer, according to physicists and oncologists who combined computer modeling and molecular biology in their discovery.
More Leukemia Current Events and Leukemia News Articles
 | Childhood Leukemia: A Guide for Families, Friends and Caregivers (3rd Edition) by Nancy Keene This most complete parent guide covers not only detailed and precise medical information about leukemia and the various treatment options, but also day-to-day practical advice on how to cope with procedures, hospitalization, family and friends, school, social and financial issues, communication, feelings, and, if therapy is not successful, the difficult issues of death and bereavement. Woven... |
 | 100 Q&A About Leukemia, Second Edition (100 Questions & Answers about . . .) by Edward D. Ball This book deals with leukemia from a doctor's and a patient's... |
 | Living Through Leukemia: A Journey to Health by Louis George Whitehead While many believe that being diagnosed with leukemia is like being handed a death sentence, South Dakota native Louis George Whitehead provides living proof that survival of this life-threatening and life-changing illness is possible. At age twenty-one, Whitehead’s doctor informs him that he is suffering from acute myeloid leukemia. After two rounds of chemotherapy and a relapse a few months... |
 | When Cancer Calls … Say Yes to Life: The Story of One Man’s Journey through Leukemia by Rusty Hammer Rusty Hammer is an inspiration We have watched his battle with admiration, for it is a tribute to the human spirit, and to the dignity and courage of a good man. Mayor Antonio Villaraigosa， City of Los Angeles Shortly after his fiftieth birthday in 2003, Rusty Hammers life irrevocably changed. Diagnosed with a rare and aggressive form of leukemia, he had two choices: fight or... |
 | Chronic Lymphocytic Leukemia: New Research This book presents recent and important research on Chronic lymphocytic leukemia (or 'chronic lymphoid leukemia'), known for short as CLL, which is a type of leukemia in which too many lymphocytes are produced. Although the malignant lymphocytes in CLL may look normal and mature, they are not and these cells may not cope effectively with infection. CLL is the most common form of leukemia in... |
 | Hairy Cell Leukemia Medical Guide by Qontro Medical Guides The Hairy Cell Leukemia Medical Guide is a publication which has been designed to better help readers understand Hairy Cell Leukemia. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Hairy Cell Leukemia. The Hairy Cell Leukemia Medical Guide is highly recommended for those interested in... |
 | Acute Myelogenous Leukemia (Contemporary Hematology) Acute Myelogenous Leukemia is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities. Bringing together new concepts and findings in the basic and... |
 | Adult Leukemia (ACS ATLAS OF CLINICAL ONCOLOGY) by Peter H. Wiernik Adult Leukemia summarizes advances in leukemia biology and treatment. It discusses the most successful treatments currently available and examines the remaining obstacles to a cure. Dr. Wiernik's team at New York Medical College has done seminal work in clinical investigation as well as patient management in the leukemias. The subject lends itself particularly well to color illustrations, a key... |
 | Understanding Leukemias, Lymphomas and Myelomas by Tariq Mughal, John M. Goldman, Sabena Mughal A practical, easy-to-use guide to leukemias and lymphomas, Understanding Leukemia and Lymphoma is an invaluable text for everyone involved with these conditions, from specialists in training to interested patients. Using straightforward terminology and extensive color figures to describe and illustrate the current procedures involved in diagnosis and treatment, this is a ready source of up to... |
| Leukemia and Allied Disorders by Forkner Claude E. |
| © 2008 BrightSurf.com |